# Comprehensive Health Update — April 2026

**Patient**: Kim Hansen, Male, Age 51 (DOB: 20/07/1974)
**Generated**: 2026-04-26
**Builds on**: `docs/health-report-2026-01.md` (Feb 2026 baseline analysis), `docs/diet-optimization-feb-2026.md` (Feb intervention plan)
**Trigger**: 3-month follow-up review before scheduled April retest.

The Jan 2026 blood numbers themselves are unchanged. This update focuses on dynamic signal drift since February and adjusts the action plan.

---

## Headline Signal: Drift Since February

| Signal | Feb 2026 | Now (Apr 2026) | Δ | Direction |
|---|---|---|---|---|
| WHOOP Recovery (14d avg) | 79.2% | 64.7% | −15 pp | Worsened |
| Sleep (14d avg) | 7.5h | 7.2h | −18 min | Worsened |
| HRV | 53.2 ms | 53.7 ms | flat | Holding |
| RHR | ~56 (baseline) | 52.8 | −3 bpm | Improved |
| Strain avg | 12.6 | 8.4 | −4.2 | Lighter |
| Composite bio age | 42.1 | 45.8 | +3.7 yr | Worsened |
| Meditation (~30d) | 26 | 6 | −77% | Collapsed |
| Tennis elbow | none | bilateral | new | New |
| Knee soreness | none | left, 2/5 | new | New |

Strain DOWN, RHR DOWN, HRV stable — yet recovery DOWN, sleep DOWN, bio age UP, meditation collapsed, two new overuse injuries. Pattern looks like **psychological / sleep-debt drift** with downstream physical wear from sport-mix shift (more pickleball, more cardio, less recovery practice). Meditation collapse is the most actionable lever — your CRP-0.4 outcome was partly built on that.

`[sourced: Irwin 2016, Biol Psychiatry 80:40 — sleep loss elevates CRP and IL-6]`
`[pattern: weak — composite bio age volatility over 3 months can be measurement noise; underlying WHOOP Age is unchanged at 41.1]`

---

## 1. Cross-correlations: Blood Markers ↔ Lifestyle

**Lipid drift (TC 5.0→6.1, LDL 3.3→4.1, ApoB 1.12) ↔ saturated fat history.** Already addressed in Feb plan. Expected April delta: ApoB to ~0.95–1.05.
`[sourced: Neelakantan 2020, Circulation — coconut oil raises LDL more than other plant oils]`

**SHBG 76 ↔ low body fat + endurance volume + fasting.** Partly the *price* of your lifestyle, not pure pathology — Free T 336 pmol/L is fine. Lever: resistance training frequency.
`[sourced: Selva 2007, Endocrinology — endurance/CR both elevate SHBG via hepatic regulation]`

**HbA1c 5.4% ↔ sleep + glucose loading.** You don't have a glucose problem; you have a sleep-quality issue suppressing insulin sensitivity. 7.5h → 8h has more leverage than further dietary tightening.
`[sourced: Spiegel 2009, J Clin Endocrinol Metab — sleep restriction reduces insulin sensitivity ~30-40% within a week]`

**Hcy 10 ↔ Danish ancestry + delayed B-complex start.** Confirm 100% adherence for the next 14 days before April draw or the result is uninterpretable.
`[sourced: Tinelli 2019, Front Endocrinol — MTHFR variants reduce 5-MTHF synthesis; Northern European C677T allele frequency 30-40%]`

**Lp(a) 72 nmol/L — re-classify.** EAS 2022 rule-out threshold = <75 nmol/L. At 72 you're under by a hair. **Low risk, not borderline** — but at the upper edge of "low."
`[sourced: Kronenberg 2022, EAS Lp(a) Consensus, Eur Heart J 43:3925]`

**Recovery decline ↔ meditation collapse + sleep loss + new injuries.** Strain is *lower*, so this isn't volume. The PNS recovers from psychological load — meditation 26→6 is the changed variable.
`[sourced: Irwin 2016 — psychosocial stress + sleep loss share an inflammatory axis]`

---

## 2. Specific Dietary Changes (additions to Feb plan)

The Feb plan is sound. Don't re-engineer. Three additions for the next 3-month block:

1. **Portfolio Diet bolt-on** — if April ApoB still >1.0, add four pillars: ≥45g/d plant protein (soy, lentils), ≥45g viscous fiber (psyllium 10g + oats + eggplant), 45g nuts, 2g/d plant sterols. RCT effect: **LDL −13.8%, ApoB −10.4%** at 6 mo full adherence.
   `[sourced: Chiavaroli 2018, Prog Cardiovasc Dis 61:43 — Portfolio Diet meta-analysis]`

2. **Glycine 3g pre-bed** for sleep latency / quality. Cheap, well-tolerated.
   `[sourced: Yamadera 2007, Sleep & Biol Rhythms 5:126 — 3g glycine improves subjective sleep quality]` `[pattern: weak — small studies]`

3. **DO NOT push protein higher for SHBG.** Urea trending up (4.7→4.9→6.5→7.4). Confirm eGFR stable on April panel first.
   `[sourced: Marckmann 2015, Am J Kidney Dis 66:546 — high-protein reduces eGFR in some adults; reversible]`

---

## 3. Supplement Recommendations

**Keep (no change)**: Omega-3 2,500mg, Vitamin K2, Mg glycinate 400mg, Creatine 5g, Blueprint Longevity Mix + Essential.

**Verify before April retest**:
- **Methylated B-complex** — biggest Feb addition for Hcy. Confirm 100% adherence next 14 days minimum before draw.

**Consider adding**:
- **Glycine 3g pre-bed** (see §2).
- **Boron 6mg/day** — was deferred in Feb. If April SHBG still ≥70, reconsider.
  `[sourced: Naghii 2011, J Trace Elem Med Biol 25:54 — 10mg/d reduced SHBG ~10% in 1 wk, n=8]` `[pattern: weak — small n, single study]`

**Do NOT add right now**:
- Bergamot, red yeast rice, citrus extracts for ApoB. Feb plan is mid-flight; new variables destroy attribution.
- Berberine for HbA1c — same reason.

---

## 4. Activity / Training Adjustments

Current 30-day profile: 14 strength (~3.3×/wk), ~60 cardiovascular sessions, 6 meditation, 3 pickleball — and bilateral tennis elbow appeared with pickleball addition.

**Adjustments, ranked:**

1. **Treat the elbows now.** Tyler / FlexBar protocol: 3×15 daily, ~4 sec eccentric per rep, progress paddle colour as easy. Tyler 2010 RCT: 81% pain reduction, 72% strength gain at 7 weeks. Pickleball known cause: elbow/forearm = 18% of pickleball injuries, 78% overuse.
   `[sourced: Tyler 2010, J Shoulder Elbow Surg 19:917]` `[sourced: JOSPT Open 2026 — pickleball upper-extremity injury study]`

2. **Restore meditation frequency before April panel.** Cheapest, highest-leverage move on CRP/recovery/cortisol stack. 26→6 + recovery −15 pp is the relationship to act on.
   `[sourced: Irwin 2016, Biol Psychiatry 80:40]`

3. **Hit 4×/week strength.** Currently 3.3×. The 4th session is the SHBG / Free T / glucose tolerance lever.
   `[sourced: West 2010, J Appl Physiol 108:60 — resistance training acute T response; chronic Free T effect requires consistent ≥3×/wk with progressive overload]`

4. **Cap pickleball at 2×/week with bilateral elbow active.** FlexBar before play, not after. Same for grip-heavy MTB.

5. **Sleep is still the #1 health intervention left.** 7.2 → 8.0h = 48-min gain. Worth more than any supplement.
   `[sourced: Cappuccio 2011, Eur Heart J 32:1484 — 474k subjects, short sleep +48% CHD risk]`

---

## 5. Follow-up Tests — Schedule This Week

Full panel + additions list in `health-report-2026-01.md` §12. Don't relitigate; book it.

**Critical reminders**:
- **Fasting** 12+ hours (Jan was random — useless for HOMA-IR).
- **Stop creatine 48h pre-draw** — likely contributed to 2024 eGFR-72 dip.
- **Add to panel**: Omega-3 Index, fasting glucose, IGF-1, DHEA-S, Vit D 25-OH, **APOE genotype** (one-time — changes lifetime lipid management aggressiveness).
- **Request CAC scan from Dr Friel.** ApoB is risk math; CAC is ground truth for someone your age.
  `[sourced: Attia, Outlive 2023 — CAC = ground truth for lifetime CV risk decisions]`

**Sequence:**
1. Today/tomorrow → call SNP, book draw morning (12h fasted).
2. 48h before draw → stop standalone creatine.
3. Same week → book Dr Friel review + CAC + APOE order.

---

## 6. Priority-Ranked Action Items

| # | Action | Why now | Time |
|---|---|---|---|
| 1 | **Restore daily meditation** (even 5 min) | Largest lever for recovery/CRP/cortisol; free; immediate | Today |
| 2 | **Book April retest + Dr Friel review** | Whole 3-mo plan bet on this checkpoint | This week |
| 3 | **Verify B-complex 100% adherence next 14d** | Otherwise April Hcy result uninterpretable | Today |
| 4 | **Start FlexBar/Tyler protocol bilateral** | Bilateral elbow at 51 + grip sport = chronic if not loaded eccentrically | This week |
| 5 | **Push sleep 7.2 → 7.5h floor, 8.0h target** | The ONE thing left with paradigm-level CV/glucose/T impact | Tonight |
| 6 | **Cap pickleball at 2×/week + FlexBar warmup** | Don't lose the sport, stop manufacturing tendinopathy | Next session |
| 7 | **Hit 4×/week strength (currently 3.3)** | SHBG / Free T / glucose lever | This week |
| 8 | **Stop creatine 48h pre-draw** | Avoids 2024-style eGFR false alarm | Pre-draw |
| 9 | **Hold all new supplements until April results** | Don't blow up attribution | Now |
| 10 | **If April ApoB still >1.0 → Portfolio Diet, NOT statin yet** | One more dietary block before pharma | Post-results |

---

## What's Labelled `[no basis]`

- The bio age jump (42.1 → 45.8 composite) **may be measurement noise** — underlying logged WHOOP Age is unchanged at 41.1. Watch one more cycle before treating as real trend.
- Exact magnitude of "30 min less sleep → X% more CRP" — literature shows directional risk, not precise dose-response at that step size.
- ESC/EAS does NOT publish guideline ApoB targets by risk tier; commonly-cited <80 / <65 are interpolations, not formal targets. Attia's <60 mg/dL ceiling is well-reasoned opinion, not consensus.

---

## Source Index

- Kronenberg F, Mora S, Stroes ESG, et al. EAS Consensus on Lp(a). *Eur Heart J*. 2022;43(39):3925.
- Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Dyslipidaemia Guidelines. *Eur Heart J*. 2020;41(1):111.
- Tyler TF, Thomas GC, Nicholas SJ, McHugh MP. Eccentric exercise for lateral epicondylosis. *J Shoulder Elbow Surg*. 2010;19(6):917.
- Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration and CV outcomes meta-analysis. *Eur Heart J*. 2011;32(12):1484.
- Irwin MR, Olmstead R, Carroll JE. Sleep, inflammation meta-analysis. *Biol Psychiatry*. 2016;80(1):40.
- Chiavaroli L, et al. Portfolio Diet meta-analysis. *Prog Cardiovasc Dis*. 2018;61:43.
- Naghii MR, et al. Boron and sex steroids/SHBG. *J Trace Elem Med Biol*. 2011;25:54.
- Spiegel K, et al. Sleep restriction and insulin sensitivity. *J Clin Endocrinol Metab*. 2009.
- Marckmann P, et al. High-protein and renal function. *Am J Kidney Dis*. 2015;66:546.
- West DWD, et al. Resistance training and acute T response. *J Appl Physiol*. 2010;108:60.
- Yamadera W, et al. Glycine and sleep quality. *Sleep & Biol Rhythms*. 2007;5:126.
- Selva DM, Hammond GL. SHBG hepatic regulation. *Endocrinology*. 2007.
- Tinelli C, et al. MTHFR and homocysteine. *Front Endocrinol*. 2019.
- Attia P. *Outlive*. 2023 (ApoB ceiling, CAC ground truth — opinion, well-reasoned, not guideline).
- JOSPT Open 2026 + Inj Epidemiol 2025 — pickleball injury patterns.
- Forrester JD et al. Pickleball ED incidence 10-yr analysis. *Inj Epidemiol*. 2025.

---

*Generated: 2026-04-26 | Cross-referenced with: Jan 2026 blood panel, WHOOP 14d, activity tracker 30d, body focus areas, current supplement stack, Feb 2026 intervention plan*